ClinicalTrials.gg
CompletedNCT05471947Updated Mar 17, 2025

TCA 15% Chemical Peel for Improvement in Hand Lentigines

A Phase 4 interventional study of 15% Trichloroacetic acid + 3% glycolic acid in Photoaging and Lentigo, sponsored by Main Line Center for Laser Surgery. Completed at 1 site in United States. Open to participants aged 22 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-17.

Sponsored by Main Line Center for Laser Surgery · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
22 Years and older
Sex
All
01

Study summary

This study will evaluate the efficacy of the a 15% trichloroacetic acid + 3% glycolic acid peel combination for treatment of lentigines on the hands. This peel combination is sold over the counter. Patients will receive 3 treatments (spaced 4 weeks).

Read the detailed description

This clinical investigation is a prospective study consisting of a screening visit, 3 treatment visits, and 1 follow-up visit. Baseline and post-treatment photos will be graded and compared.

A total of 20 patients will be recruited. Following informed consent and screening, subjects' dorsal hands will be photographed.

Patients will receive 3 treatments with the 15% TCA + 3% glycolic acid peel every 4-6 weeks on the dorsal hands. Post-treatment, patients will be instructed to apply Aquaphor to the treated area twice daily for 5 days. Patients' hands will be photographed at each visit.

Four to six weeks after their final treatment, subjects will return for photography.

02

Conditions studied

  • Photoaging
  • Lentigo

Browse trials for

Keywords

  • Photoaging
  • Chemical Peel
  • Lentigines
  • Hand Rejuvenation
03

In context

Lentigo

28 studies on the registry are indexed under Lentigo; 2 are open to participants now.

This study's enrollment of 20 is below the median of 30 across 25 interventional studies indexed under Lentigo.

Browse Lentigo studies →

Lead sponsor

Main Line Center for Laser Surgery is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >21
  • No laser, chemical peel, neuromodulator, filler treatment to the hands in >3 months
  • At least 5 lentigines on each hand

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Breastfeeding
  • Allergy to trichloroacetic acid
  • Allergy to glycolic acid
  • Open wounds on treatment area (hands)
  • Active inflammatory disease on treatment area such as atopic dermatitis, psoriasis, dermatomyositis
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Treatment

    Treatment of hand lentigines with 15% trichloroacetic acid + 3% glycolic acid

    Drug: 15% Trichloroacetic acid + 3% glycolic acid

Interventions

  • Drug15% Trichloroacetic acid + 3% glycolic acid

    Drug pages: Trichloroacetic Acid · Glycolic acid

    Treatment of the hand with an over-the-counter chemical peel containing 15% trichloroacetic acid + 3% glycolic acid

    Also known as: 15% TCA + 3% GA

06

What researchers measure

Primary outcomes

  1. Improvement in hand lentigines on a 5-point scale

    Photos will be graded on a 5 point scale (0=no change, 1=1-25% change, 2=26-50% change, 3=51-75% change, 4=76-100% change)

    Time frame: 4-6 weeks after last treatment

Secondary outcomes

  1. Improvement in hand lentigines using the Global Aesthetic Improvement Scale

    The GAIS is a validated scale assessing overall change after aesthetic procedures

    Time frame: 4-6 weeks after last treatment

07

Study locations

1 site
  • Main Line Center for Laser Surgery
    Ardmore, Pennsylvania 19003, United States
08

References and documents

Publications

  • Cook KK, Cook WR Jr. Chemical peel of nonfacial skin using glycolic acid gel augmented with TCA and neutralized based on visual staging. Dermatol Surg. 2000 Nov;26(11):994-9. doi: 10.1046/j.1524-4725.2000.026011994.x. PubMed 11096382 ↗
  • Abd Elazim NE, Makboul R, Botros SN, Awad SM. Cryopeeling versus trichloroacetic acid peeling in the treatment of solar lentigines: Effect on epidermal Langerhans cells. Dermatol Ther. 2020 May;33(3):e13288. doi: 10.1111/dth.13288. Epub 2020 Mar 9. PubMed 32118343 ↗
  • Raziee M, Balighi K, Shabanzadeh-Dehkordi H, Robati RM. Efficacy and safety of cryotherapy vs. trichloroacetic acid in the treatment of solar lentigo. J Eur Acad Dermatol Venereol. 2008 Mar;22(3):316-9. doi: 10.1111/j.1468-3083.2007.02409.x. Epub 2007 Oct 18. PubMed 18021205 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05471947
Lead sponsor
Main Line Center for Laser Surgery
Responsible party
Kachiu Lee, MD (Principal Investigator, Main Line Center for Laser Surgery) — Principal investigator
First posted
Jul 25, 2022
Start date
Mar 15, 2023
Primary completion
Dec 30, 2023
Completion
Dec 1, 2024
Last update
Mar 17, 2025

Study contacts

Kachiu Lee, MD
principal investigator · Main Line Center for Laser Surgery

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Trichloroacetic Acid · Glycolic acid

Start the discussion